title: Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
authors.forename: S
authors.initials: S
authors.lastname: Nair
authors.forename: O
authors.initials: O
authors.lastname: Saeed
authors.forename: H
authors.initials: H
authors.lastname: Shahab
authors.forename: K
authors.initials: K
authors.lastname: Sedky
authors.forename: D
authors.initials: D
authors.lastname: Garver
authors.forename: S
authors.initials: S
authors.lastname: Lippmann
mesh_terms: D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis; D001590:Benztropine / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010608:Pharyngeal Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy; D014609:Uvula / Q000187:drug effects* / Q000503:physiopathology*
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001590:Benztropine; D018967:Risperidone